🔎 Trials Near Me

Почетна › Мијелодиспластични синдроми › Kalifornija

Kliničke studije za Мијелодиспластични синдроми u državi Kalifornija

41 studija za Мијелодиспластични синдроми traži učesnike na lokacijama u državi Kalifornija.

Gradovi u državi Kalifornija

Zvanični tekst studije (na engleskom)

Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell Transplant

  • City of Hope Medical Center, Duarte
Тражи се учесникФаза 1
Узраст од 18 до 75 · Оба пола · Ажурирано 9. 11. 2026. · NCT06996119

A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

  • City of Hope, Duarte
  • Los Angeles Cancer Network, Glendale
  • UC San Diego Moores Cancer Center, La Jolla
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 6. 11. 2026. · NCT06499285

HPC Offered for PRESERVE Expansion

  • City of Hope, Duarte
Тражи се учесникОпсервациона студија
Узраст од 12 до 80 · Оба пола · Ажурирано 6. 11. 2026. · NCT07145411

Study of R289 in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS)

  • University of California, Los Angeles, Los Angeles
  • University of California, Irvine, Orange
  • Stanford Cancer Institute, Palo Alto
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 6. 11. 2026. · NCT05308264

A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Lower Risk Myelodysplastic Syndromes (LR-MDS) Who Need Regular Blood Transfusions

  • City of Hope - Comprehensive Cancer Center (CCC), Duarte
  • Providence Medical Group, Santa Rosa
  • Cancer & Blood Research Center, Whittier
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 6. 11. 2026. · NCT07422480

Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)

  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
  • UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06577441

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

  • Kaiser Permanente Dublin, Dublin
  • Kaiser Permanente-Fremont, Fremont
  • Kaiser Permanente Fresno Orchard Plaza, Fresno
  • и још 19
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 2. 11. 2026. · NCT05564390

225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome

  • City of Hope Medical Center, Duarte
Тражи се учесникФаза 1
Узраст од 18 до 70 · Оба пола · Ажурирано 30. 10. 2026. · NCT06287944

Study of REM-422 in Patients With AML or Higher Risk MDS

  • City of Hope, Duarte
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 29. 10. 2026. · NCT06297941

CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

  • City of Hope, Duarte
  • UCLA, Los Angeles
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 28. 10. 2026. · NCT05143996

CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant

  • City of Hope Medical Center, Duarte
Тражи се учесникФаза 2Здраве особе су добродошле
Узраст од 18 до 75 · Оба пола · Ажурирано 23. 10. 2026. · NCT06059391

A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant

  • City of Hope Medical Center, Duarte
Тражи се учесникФаза 1Здраве особе су добродошле
Узраст од 18 до 75 · Оба пола · Ажурирано 23. 10. 2026. · NCT07020533

Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia

  • City of Hope - Duarte, Duarte
  • City of Hope - Lennar, Irvine
  • UCLA, Los Angeles
  • и још 1
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 22. 10. 2026. · NCT05320198

Olutasidenib for the Treatment of Patients With IDH1 Mutated AML, MDS or CMML After Donor Hematopoietic Cell Transplant

  • City of Hope Medical Center, Duarte
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 20. 10. 2026. · NCT06543381

A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)

  • City of Hope National Medical Center, Duarte
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 19. 10. 2026. · NCT04419649

Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDS

  • City of Hope National Medical Center, Duarte
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 16. 10. 2026. · NCT06846606

Ruxolitinib With Tacrolimus and Methotrexate for the Prevention of Graft Versus Host Disease in Pediatric and Young Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome

  • City of Hope Medical Center, Duarte
Тражи се учесникФаза 2
Узраст од 2 до 22 · Оба пола · Ажурирано 14. 10. 2026. · NCT06128070

Total Marrow and Lymphoid Irradiation in Combination With Fludarabine and Melphalan as Conditioning for Allogeneic Peripheral Blood Stem Cell Hematopoietic Cell Transplant in Older Patients With Refractory and Relapsed Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome

  • City of Hope Medical Center, Duarte
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 8. 10. 2026. · NCT07582172

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

  • Keck School of Medicine of USC, Los Angeles
  • UC Irvine Health - Chao Family Comprehensive Cancer Center, Orange
Тражи се учесникФаза 2/3
Узраст 18 и старији · Оба пола · Ажурирано 6. 10. 2026. · NCT04256317

A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

  • City of Hope, Duarte
  • UC Davis, Sacramento
  • Stanford Health Care, Stanford
Тражи се учесникФаза 1
Узраст од 12 до 78 · Оба пола · Ажурирано 29. 9. 2026. · NCT03802695

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

  • Kaiser Permanente Downey Medical Center, Downey
  • Loma Linda University Medical Center, Loma Linda
  • Miller Children's and Women's Hospital Long Beach, Long Beach
  • и још 8
Тражи се учесникФаза 1/2
До 22 година · Оба пола · Ажурирано 25. 8. 2026. · NCT04726241

Study of QUAIL-100 in Pediatric and Young Adult Participants With High-Risk Hematologic Malignancies Who Have Received a Hematopoietic Stem Cell Transplantation

  • Lucille Packard Children's Hospital of Stanford University, Palo Alto
Тражи се учесникФаза 1
18 Months – 39 Years · Оба пола · Ажурирано 21. 8. 2026. · NCT07573111

ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies

  • Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 18. 8. 2026. · NCT06656494

TACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCT

  • Stanford University, Palo Alto
Тражи се учесникФаза 1
Узраст од 18 до 80 · Оба пола · Ажурирано 17. 8. 2026. · NCT07302776

Tagraxofusp and Azacitidine for Maintenance Treatment in Patients With CD123 Positive AML and MDS Following Donor Hematopoietic Cell Transplant

  • City of Hope Medical Center, Duarte
Тражи се учесникФаза 1
Узраст од 18 до 75 · Оба пола · Ажурирано 16. 7. 2026. · NCT06498973

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

  • UCLA Department of Medicine, Los Angeles
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 7. 7. 2026. · NCT07216443

Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning

  • City of Hope Medical Center, Duarte
Тражи се учесникФаза 2
Узраст од 18 до 80 · Оба пола · Ажурирано 29. 6. 2026. · NCT06815003

Trial for Patients w/ Advanced Hematologic Malignancies Undergoing Allogeneic HCT

  • Stanford University, Palo Alto
Тражи се учесникФаза 1
Узраст од 18 до 70 · Оба пола · Ажурирано 23. 6. 2026. · NCT06551584

SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

  • City of Hope, Duarte
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 17. 6. 2026. · NCT03113643

A Study of Momelotinib in Participants With Low-risk Myelodysplastic Syndrome

  • GSK Investigational Site, Duarte
  • GSK Investigational Site, Irvine
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 2. 6. 2026. · NCT06847867

Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

  • Beckman Research Institute of City of Hope, Duarte
  • VA Medical Center, Fresno, Fresno
  • Santa Clara Valley Medical Center, Fruitdale
  • и још 5
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 30. 4. 2026. · NCT05297734

A Study of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic Syndromes

  • City of Hope Medical Center, Duarte
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 13. 4. 2026. · NCT06146257

Curcumin to Improve Inflammation and Symptoms in Patients With Clonal Cytopenia of Undetermined Significance, Low Risk Myelodysplastic Syndrome, and Myeloproliferative Neoplasms

  • Los Angeles General Medical Center, Los Angeles
  • USC / Norris Comprehensive Cancer Center, Los Angeles
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 27. 3. 2026. · NCT06063486

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

  • Hoag Family Cancer Center, Newport Beach
  • Stanford University, Palo Alto
Тражи се учесникФаза 1/2
Узраст 12 и старији · Оба пола · Ажурирано 24. 3. 2026. · NCT04988555

Venetoclax Basket Trial for High Risk Hematologic Malignancies

  • University of California San Francisco-Benioff Children's Hospital, San Francisco
Тражи се учесникФаза 1
Узраст од 1 до 40 · Оба пола · Ажурирано 12. 3. 2026. · NCT05292664

Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML

  • University of California Davis Health (UC Davis Health), Sacramento
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 5. 1. 2026. · NCT05184842

Exercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT Survivors

  • City of Hope Medical Center, Duarte
Тражи се учесникФаза 2
Узраст од 10 до 30 · Оба пола · Ажурирано 4. 12. 2025. · NCT05194397

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Duarte
  • Massive Bio SYNERGY-AI site, Irvine
  • Massive Bio SYNERGY-AI site, La Jolla
  • и још 3
Тражи се учесникОпсервациона студија
Сви узрасти · Оба пола · Ажурирано 28. 10. 2025. · NCT03452774

A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome

  • City of Hope Medical Center, Duarte
  • University of California Los Angeles, Los Angeles
  • Stanford Cancer Center, Palo Alto
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 24. 9. 2025. · NCT06501196

Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)

  • City of Hope, Duarte
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 15. 4. 2025. · NCT06462365

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.